Setting a benchmark for resource utilization and quality of care in patients undergoing transcatheter aortic valve implantation in Europe—Rationale and design of the international BENCHMARK registry-Reference-Cited by-同舟云学术

Setting a benchmark for resource utilization and quality of care in patients undergoing transcatheter aortic valve implantation in Europe—Rationale and design of the international BENCHMARK registry

Published:2021-09-09 Issue:10 Volume:44 Page:1344-1353
ISSN:0160-9289
Container-title:Clinical Cardiology
language:en
Short-container-title:Clin Cardiol

Author:

McCalmont Gemma¹,Durand Eric²,Lauck Sandra³,Muir Douglas F.¹,Spence Mark S.⁴,Vasa‐Nicotera Mariuca⁵,Wood David³,Saia Francesco⁶,Chatel Nicolas⁷,Lüske Claudia M.⁸,Kurucova Jana⁹,Bramlage Peter⁸^ORCID,Frank Derk¹⁰¹¹

Affiliation:

1. Cardiology Department James Cook University Hospital Middlesbrough UK

2. Department of Cardiology, FHU CARNAVAL Normandie University, UNIROUEN Rouen France

3. Center for Heart Valve Innovation, St Paul's Hospital University of Vancouver Vancouver British Columbia Canada

4. Cardiology Department, Royal Victoria Hospital Belfast UK

5. Cardiology Department Frankfurt University Frankfurt Germany

6. Department of Cardiology University of Bologna Bologna Italy

7. Edwards Lifesciences Nyon Switzerland

8. Institute for Pharmacology and Preventive Medicine Cloppenburg Germany

9. Edwards Lifesciences Prague Czech Republic

10. Department of Internal Medicine III (Cardiology, Angiology and Intensive Care Medicine) University Clinical Center Schleswig‐Holstein (UKSH) Kiel Germany

11. German Center for Cardiovascular Research, partner site Hamburg/Kiel/Lübeck Kiel Germany

Funder

Edwards Lifesciences

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/clc.23711

Reference31 articles.

1. Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients

2. Systematic review and meta-analysis to compare outcomes between intermediate- and high-risk patients undergoing transcatheter aortic valve implantation